DePuy Synthes Products signed a definitive agreement with JointPoint to acquire its navigation software designed for use in hip replacement. The transaction is expected to close within 2019. DePuy Synthes plans to continue to develop and broaden JointPoint for additional orthopaedic surgery procedures.
JointPoint Navigation Software offers non-invasive computer navigation, pre-surgical digital templating and case planning to support precise analysis of implant selection and positioning. It features OneTrial®, which is used to optimize implant combinations based on pre-surgical goals with just two images, and to reduce O.R. time by limiting retrialing.
“JointPoint ties into our strategy to transform hip replacement and is specifically designed for use with the Anterior Approach, a tissue-sparing surgical technique which surgeons are increasingly utilizing and where we have long had an industry-leading presence,” said Aaron Villaruz, Vice President and Global Platform Leader, Hips, DePuy Synthes.
DePuy Synthes and JointPoint have held an exclusive agreement to market JointPoint in the U.S. since 2017. The platform will become a DePuy Synthes-owned component of the ANTERIOR ADVANTAGE which combines DePuy Synthes implants and instrumentation, technologies to optimize the surgical experience for the patient and a professional surgeon education program.
DePuy Synthes Products signed a definitive agreement with JointPoint to acquire its navigation software designed for use in hip replacement. The transaction is expected to close within 2019. DePuy Synthes plans to continue to develop and broaden JointPoint for additional orthopaedic surgery procedures.
JointPoint Navigation Software...
DePuy Synthes Products signed a definitive agreement with JointPoint to acquire its navigation software designed for use in hip replacement. The transaction is expected to close within 2019. DePuy Synthes plans to continue to develop and broaden JointPoint for additional orthopaedic surgery procedures.
JointPoint Navigation Software offers non-invasive computer navigation, pre-surgical digital templating and case planning to support precise analysis of implant selection and positioning. It features OneTrial®, which is used to optimize implant combinations based on pre-surgical goals with just two images, and to reduce O.R. time by limiting retrialing.
“JointPoint ties into our strategy to transform hip replacement and is specifically designed for use with the Anterior Approach, a tissue-sparing surgical technique which surgeons are increasingly utilizing and where we have long had an industry-leading presence,” said Aaron Villaruz, Vice President and Global Platform Leader, Hips, DePuy Synthes.
DePuy Synthes and JointPoint have held an exclusive agreement to market JointPoint in the U.S. since 2017. The platform will become a DePuy Synthes-owned component of the ANTERIOR ADVANTAGE which combines DePuy Synthes implants and instrumentation, technologies to optimize the surgical experience for the patient and a professional surgeon education program.
Copy to clipboard 
